表紙
市場調查報告書

人體生長荷爾蒙(hGH)的全球市場:各應用領域(生長激素缺乏症,透納氏症,特發性矮小症,普拉達威利症候群,小於胎齡兒),地區 2014年∼2025

Human Growth Hormone (hGH) Market Analysis By Application (Growth Hormone Deficiency, Turner Syndrome, Idiopathic Short Stature, Prader-Willi Syndrome, SGA), By Region, And Segment Forecasts, 2014 - 2025

出版商 Grand View Research, Inc. 商品編碼 600786
出版日期 內容資訊 英文 100 Pages
商品交期: 2-3個工作天內
價格
Back to Top
人體生長荷爾蒙(hGH)的全球市場:各應用領域(生長激素缺乏症,透納氏症,特發性矮小症,普拉達威利症候群,小於胎齡兒),地區 2014年∼2025 Human Growth Hormone (hGH) Market Analysis By Application (Growth Hormone Deficiency, Turner Syndrome, Idiopathic Short Stature, Prader-Willi Syndrome, SGA), By Region, And Segment Forecasts, 2014 - 2025
出版日期: 2017年12月07日內容資訊: 英文 100 Pages
簡介

生長激素缺乏症,普拉達威利症候群,原發性矮小症,小於胎齡兒(SGA)是治療使用生長激素(GH)的疾病。克雅氏病,慢性腎臟病,SHOX遺傳基因單套缺失症候群,關於努南氏症候群等其他的適應症也接受核准。全球人體生長荷爾蒙(hGH)市場預計2025年達到71億美元。腦垂體功能不全的案例增加,人體生長荷爾蒙的使用增加,預計今後數年促進市場成長。

本報告提供全球人體生長荷爾蒙(hGH)市場相關調查,市場概要,各應用領域、地區的市場趨勢,市場規模的變化與預測,市場成長要素分析,競爭情形,主要企業的簡介等,全面性資訊。

目錄

第1章 摘要整理

  • 市場概述

第2章 調查方法

  • 資訊採購
  • 資料分析

第3章 人體生長荷爾蒙(hGH)市場趨勢與範圍

  • 市場區隔和範圍
  • 滲透與成長預測製圖
  • 人體生長荷爾蒙 - SWOT分析
  • 產業分析 - 波特的五力分析
  • 競爭情形:市場地位分析

第4章 人體生長荷爾蒙(hGH)市場趨勢分析與預測:各應用領域

  • 市場分析:各應用領域
  • 生長激素缺乏症
  • 透納氏症
  • 原發性矮小症
  • 普拉達威利症候群
  • 小於胎齡兒
  • 其他

第5章 人體生長荷爾蒙(hGH)市場趨勢分析與預測:各地區

  • 市場分析
  • 北美
    • 美國
    • 加拿大
  • 歐洲
    • 英國
    • 德國
  • 亞太地區
    • 日本
    • 中國
  • 中南美
    • 巴西
    • 墨西哥
  • 中東、非洲
    • 南非

第6章 競爭情形

  • 策略架構
  • 企業簡介
目錄
Product Code: GVR-2-68038-057-6

The global human growth hormone (hGH) market is expected to reach USD 7.1 billion by 2025, according to a new report by Grand View Research, Inc. Rising cases of pituitary dysfunction and increasing use of human growth hormone are likely to drive the market in coming years.

Turner syndrome, growth hormone deficiency, Prader-Willi syndrome, idiopathic short stature, and small for gestational age (SGA) are major disorders in which growth hormone (GH) are used. Additionally, growth hormone also received an approval for other indications such as Creutzfeldt-Jakob disease, chronic kidney disease, SHOX gene haploinsufficiency, and Noonan syndrome.

Although FDA has not approved the use of hGH as anti-aging therapy, many practitioners offer injections of growth hormones at higher prices. The hGH therapy is aggressively promoted for advanced age symptoms.

hGH is anabolic as it accelerates protein synthesis and breaks down fat. Hence, athletes involved in strength demanding activities and sports are likely to use growth hormones for its anabolic effects. It is a fairly common practice among athletes and body-builders to use combination of anabolic steroids and GH for the benefits.

Further Key Findings From the Report Suggest:

  • Increasing demand for hGH due to rising growth hormone deficiency diseases and technological advancement such as recombinant DNA technology are expected to propel the market growth.
  • The growth hormone deficiency segment accounted for the highest share of the market in 2016 and is estimated to observe the fastest growth of the market. This can be attributed to increasing incidence of pituitary dysfunctioning and investment by major players for the research and development of human growth hormone drugs.
  • Turner syndrome also accounted for the significant share in the GH market. Large number of patients and effectivity of growth hormone to treat Turner's syndrome are the key reasons for the significant share in the market.
  • Geographically, North America was the largest market for GH in 2016 and is anticipated to maintain its dominance during the forecast period due to the local presence of market players, the presence of strong pipeline, and affordability of hormonal therapy.
  • Asia Pacific is estimated to witness the fastest growth during the forecast period owing to increasing healthcare expenditure, investment by market players, and large patient pool. Furthermore, increasing awareness about the therapy for short stature is likely to boost the demand for GH.
  • Some of the key players are Pfizer, Inc.; Merck & Co., Inc.; Eli Lilly and Company, Genentech, Inc., Novo Nordisk, Sandoz International GmbH, Ferring Holding SA, and Ipsen.

Table of Contents

Chapter 1 Executive Summary

  • 1.1 Market Snapshot

Chapter 2 Research Methodology

  • 2.1 Information Procurement
  • 2.2 Data Analysis

Chapter 3 Human Growth Hormone Market Variables, Trends & Scope

  • 3.1 Market Segmentation & Scope
    • 3.1.1 Market Driver Analysis
      • 3.1.1.1 Rising use of HGH for anti-aging and performance enhancing purposes
      • 3.1.1.2 Increase in number of pituitary dysfunction cases
    • 3.1.2 Market Restraint Analysis
      • 3.1.2.1 Adverse effects
      • 3.1.2.2 Off-label use and complex regulatory control
  • 3.2 Penetration & Growth Prospect Mapping
  • 3.3 Human growth hormone - SWOT Analysis, by Factor (Political & Legal, Economic and Technological)
  • 3.4 Industry Analysis - Porter's
  • 3.5 Competitive Landscape: Market Position Analysis (Based on Applications, Regional Presence, and Recent Updates)

Chapter 4 Human Growth Hormone Market: Application Estimates & Trend Analysis

  • 4.1 Human Growth Hormone: Application Analysis
  • 4.2 Growth Hormone Deficiency
    • 4.2.1 Growth Hormone Deficiency Market, 2014 - 2025 (USD Million)
  • 4.3 Turner syndrome
    • 4.3.1 Turner Syndrome Market, 2014 - 2025 (USD Million)
  • 4.4 Idiopathic short stature
    • 4.4.1 Idiopathic Short Stature Market, 2014 - 2025 (USD Million)
  • 4.5 Prader-Willi Syndrome
    • 4.5.1 Prader-Willi syndrome market, 2014 - 2025 (USD Million)
  • 4.6 Small for Gestational Age
    • 4.6.1 Small for Gestational Age Market, 2014 - 2025 (USD Million)
  • 4.7 Others
    • 4.7.1 Others market, 2014 - 2025 (USD Million)

Chapter 5 Human Growth Hormone Market: Regional Estimates & Trend Analysis

  • 5.1 Human Growth Hormone Market: Regional Movement analysis
  • 5.2 North America
    • 5.2.1 North America Human Growth Hormone Market, 2014 - 2025 (USD Million)
    • 5.2.2 U.S.
      • 5.2.2.1 U.S. human growth hormone market, 2014 - 2025 (USD Million)
    • 5.2.3 Canada
      • 5.2.3.1 Canada human growth hormone market, 2014 - 2025 (USD Million)
  • 5.3 Europe
    • 5.3.1 Europe human Growth Hormone Market, 2014 - 2025 (USD Million)
    • 5.3.2 UK
      • 5.3.2.1 UK human growth hormone market, 2014 - 2025 (USD Million)
    • 5.3.3 Germany
      • 5.3.3.1 Germany human growth hormone market, 2014 - 2025 (USD Million)
    • 5.3.4 Asia Pacific
      • 5.3.4.1 Asia Pacific human growth hormone market, 2014 - 2025 (USD Million)
    • 5.3.5 Japan
      • 5.3.5.1 Japan human growth hormone market, 2014 - 2025 (USD Million)
    • 5.3.6 China
      • 5.3.6.1 China human growth hormone market, 2014 - 2025 (USD Million)
  • 5.4 Latin America
    • 5.4.1 Latin America human growth hormone market, 2014 - 2025 (USD Million)
    • 5.4.2 Brazil
      • 5.4.2.1 Brazil human growth hormone market, 2014 - 2025 (USD Million)
    • 5.4.3 Mexico
      • 5.4.3.1 Mexico human growth hormone market, 2014 - 2025 (USD Million)
  • 5.5 Middle East and Africa (MEA)
    • 5.5.1 MEA human Growth Hormone Market, 2014 - 2025 (USD Million)
    • 5.5.2 South Africa
      • 5.5.2.1 South Africa human growth hormone market, 2014 - 2025 (USD Million)

Chapter 6 Competitive Landscape

  • 6.1 Strategy framework
  • 6.2 Company Profiles
    • 6.2.1 Novo Nordisk
      • 6.2.1.1 Company Overview
      • 6.2.1.2 Financial Performance
      • 6.2.1.3 Product Benchmarking
      • 6.2.1.4 Strategic Initiatives
    • 6.2.2 Pfizer
      • 6.2.2.1 Company Overview
      • 6.2.2.2 Financial Performance
      • 6.2.2.3 Product Benchmarking
      • 6.2.2.4 Strategic Initiatives
    • 6.2.3 Eli Lilly
      • 6.2.3.1 Company Overview
      • 6.2.3.2 Financial Performance
      • 6.2.3.3 Product Benchmarking
    • 6.2.4 Sandoz International GmbH
      • 6.2.4.1 Company Overview
      • 6.2.4.2 Product Benchmarking
      • 6.2.4.3 Strategic Initiatives
    • 6.2.5 Merck
      • 6.2.5.1 Company Overview
      • 6.2.5.2 Financial Performance
      • 6.2.5.3 Product Benchmarking
      • 6.2.5.4 Strategic Initiatives
    • 6.2.6 Genentech
      • 6.2.6.1 Company Overview
      • 6.2.6.2 Product Benchmarking
    • 6.2.7 Ferring Pharmaceuticals
      • 6.2.7.1 Company Overview
      • 6.2.7.2 Product Benchmarking
      • 6.2.7.3 Strategic Initiatives
    • 6.2.8 Ipsen
      • 6.2.8.1 Company Overview
      • 6.2.8.2 Financial Performance
      • 6.2.8.3 Product Benchmarking

List of Tables

  • TABLE 1 North America human growth hormone market, by country, 2014 - 2025 (USD Million)
  • TABLE 2 North America human growth hormone market, by type, 2014 - 2025 (USD Million)
  • TABLE 3
  • TABLE 4 U.S. human growth hormone market, by type, 2014 - 2025 (USD Million)
  • TABLE 5 Canada human growth hormone market, by type, 2014 - 2025 (USD Million)
  • TABLE 6 Europe human growth hormone market, by country, 2014 - 2025 (USD Million)
  • TABLE 7 Europe human growth hormone market, by type, 2014 - 2025 (USD Million)
  • TABLE 8 U.K. human growth hormone market, by type, 2014 - 2025 (USD Million)
  • TABLE 9 Germany human growth hormone market, by type, 2014 - 2025 (USD Million)
  • TABLE 10 Asia Pacific human growth hormone market, by country, 2014 - 2025 (USD Million)
  • TABLE 11 Asia Pacific human growth hormone market, by type, 2014 - 2025 (USD Million)
  • TABLE 12 Japan human growth hormone market, by type, 2014 - 2025 (USD Million)
  • TABLE 13 China human growth hormone market, by type, 2014 - 2025 (USD Million)
  • TABLE 14 Latin America human growth hormone market, by country, 2014 - 2025 (USD Million)
  • TABLE 15 Latin America human growth hormone market, by type, 2014 - 2025 (USD Million)
  • TABLE 16 Brazil human growth hormone market, by type, 2014 - 2025 (USD Million)
  • TABLE 17 Mexico human growth hormone market, by type, 2014 - 2025 (USD Million)
  • TABLE 18 Middle East & Africa human growth hormone market, by country, 2014 - 2025 (USD Million)
  • TABLE 19 Middle East & Africa human growth hormone market, by type, 2014 - 2025 (USD Million)
  • TABLE 20 South Africa human growth hormone market, by type, 2014 - 2025 (USD Million)

List of Figures

  • FIG. 1 Market summary 2016, (USD Million)
  • FIG. 2 Market research process
  • FIG. 3 Information procurement
  • FIG. 4 Primary research pattern
  • FIG. 5 Market research approaches
  • FIG. 6 Value chain based sizing & forecasting
  • FIG. 7 QFD modeling for market share assessment
  • FIG. 8 Market trends & outlook
  • FIG. 9 Market segmentation & scope
  • FIG. 10 Market driver relevance analysis (Current & future impact)
  • FIG. 11 Global geriatric population, 2015 - 2030 (Million)
  • FIG. 12 Market restraint relevance analysis (Current & future impact)
  • FIG. 13 Penetration & growth prospect mapping
  • FIG. 14 SWOT analysis, by factor (political & legal, economic and technological)
  • FIG. 15 Porter's Five Forces Analysis
  • FIG. 16 Human growth hormone competitive landscape: Market position analysis (based on applications, regional presence)
  • FIG. 17 Human growth hormone market, application outlook: Key takeaways
  • FIG. 18 Human Growth Hormone: Application movement analysis
  • FIG. 19 Growth hormone deficiency market, 2014 - 2025 (USD Million)
  • FIG. 20 Turner syndrome market, 2014- 2025 (USD Million)
  • FIG. 21 Idiopathic short stature market, 2014 - 2025 (USD Million)
  • FIG. 22 Prader-Willi syndrome market, 2014 - 2025 (USD Million)
  • FIG. 23 Small for gestational age market, 2014 - 2025 (USD Million)
  • FIG. 24 Others market, 2014 - 2025 (USD Million)
  • FIG. 25 Regional market place: Key takeaways
  • FIG. 26 Human growth hormone market: Regional movement analysis
  • FIG. 27 North America human growth hormone market, 2014 - 2025 (USD Million)
  • FIG. 28 The U.S. human growth hormone market, 2014 - 2025 (USD Million)
  • FIG. 29 Canada human growth hormone market, 2014 - 2025 (USD Million)
  • FIG. 30 Europe human growth hormone market, 2014 - 2025 (USD Million)
  • FIG. 31 The UK human growth hormone market, 2014 - 2025 (USD Million)
  • FIG. 32 Germany human growth hormone market, 2014 - 2025 (USD Million)
  • FIG. 33 Asia Pacific human growth hormone market, 2014 - 2025 (USD Million)
  • FIG. 34 Japan human growth hormone market, 2014 - 2025 (USD Million)
  • FIG. 35 China human growth hormone market, 2014 - 2025 (USD Million)
  • FIG. 36 Latin America human growth hormone market, 2014 - 2025 (USD Million)
  • FIG. 37 Brazil human growth hormone market, 2014 - 2025 (USD Million)
  • FIG. 38 Mexico human growth hormone market, 2014 - 2025 (USD Million)
  • FIG. 39 MEA human growth hormone market, 2014 - 2025 (USD Million)
  • FIG. 40 South Africa human growth hormone market, 2014 - 2025 (USD Million)
  • FIG. 41 Strategy framework
Back to Top